Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RUSSELL A SETTIPANE

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1053470476
CMS profile
92866
Location
MIDDLETOWN, RI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$162,930.63

262 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 6; records 101–150 of 262 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RUSSELL A SETTIPANE

NPI 1053470476 · CMS profile ID 92866

Allopathic & Osteopathic Physicians / Allergy & Immunology

MIDDLETOWN, RI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 6; records 101–150 of 262 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1053470476?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RUSSELL A SETTIPANE, NPI 1053470476, CMS profile ID 92866. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 262 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1053470476?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). RUSSELL A SETTIPANE, NPI 1053470476, CMS profile ID 92866. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 262 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1053470476?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
RUSSELL A SETTIPANE, NPI 1053470476, CMS profile ID 92866, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 6; records 101–150 of 262 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1053470476?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

262 matching records · $162,930.63 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 262 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 262.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $31.8007/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116656333 CMS
Genentech USA, Inc. $21.0207/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133102960 CMS
Novartis Pharmaceuticals Corporation $1.1207/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087270967 CMS
AstraZeneca Pharmaceuticals LP $71.0206/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104768198 CMS
AstraZeneca Pharmaceuticals LP $14.2306/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105626079 CMS
AstraZeneca Pharmaceuticals LP $83.9006/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105868077 CMS
AstraZeneca Pharmaceuticals LP $2,500.0006/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105894062 CMS
AstraZeneca Pharmaceuticals LP $34.7106/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105866836 CMS
GENZYME CORPORATION $3,146.0006/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139610406 CMS
Novartis Pharmaceuticals Corporation $13.9906/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087270965 CMS
AstraZeneca Pharmaceuticals LP $29.9006/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105534626 CMS
AstraZeneca Pharmaceuticals LP $21.3906/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104538274 CMS
AstraZeneca Pharmaceuticals LP $1,174.4206/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105533628 CMS
AstraZeneca Pharmaceuticals LP $19.8506/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104199471 CMS
AstraZeneca Pharmaceuticals LP $229.9006/13/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104491168 CMS
AstraZeneca Pharmaceuticals LP $16.8106/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104532424 CMS
AstraZeneca Pharmaceuticals LP $38.7006/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105792034 CMS
AstraZeneca Pharmaceuticals LP $9.7406/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105882142 CMS
Genentech USA, Inc. $137.6406/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133102939 CMS
Genentech USA, Inc. $11.3506/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133102943 CMS
Genentech USA, Inc. $4,800.0006/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133102947 CMS
Genentech USA, Inc. $751.4206/13/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133102951 CMS
Novartis Pharmaceuticals Corporation $4.6606/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087270963 CMS
Novartis Pharmaceuticals Corporation $4.1106/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087270961 CMS
AstraZeneca Pharmaceuticals LP $2,150.0006/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104419775 CMS
AstraZeneca Pharmaceuticals LP $1,875.0006/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105472097 CMS
Grifols USA, LLC $4,200.0006/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124722215 CMS
Grifols USA, LLC $58.3606/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124722217 CMS
Grifols USA, LLC $53.6306/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124722219 CMS
Grifols USA, LLC $5.0006/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124722221 CMS
Grifols USA, LLC $124.0006/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124722223 CMS
Grifols USA, LLC $438.6006/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124722225 CMS
Grifols USA, LLC $312.9206/06/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124722227 CMS
Grifols USA, LLC $122.5606/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124734013 CMS
Novartis Pharmaceuticals Corporation $15.7706/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087270959 CMS
AstraZeneca Pharmaceuticals LP $101.8206/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104584744 CMS
AstraZeneca Pharmaceuticals LP $28.1406/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104597514 CMS
GlaxoSmithKline, LLC. $16.0906/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116241329 CMS
AstraZeneca Pharmaceuticals LP $3,200.0006/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104654867 CMS
Grifols USA, LLC $1,200.0005/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124722213 CMS
AstraZeneca Pharmaceuticals LP $4,300.0005/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104264395 CMS
Novartis Pharmaceuticals Corporation $2.7705/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087270957 CMS
Regeneron Healthcare Solutions, Inc. $1,342.0805/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114167016 CMS
AstraZeneca Pharmaceuticals LP $3,200.0005/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105841943 CMS
LEO Pharma Inc. $33.3305/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152650597 CMS
Novartis Pharmaceuticals Corporation $3.2205/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087270955 CMS
AstraZeneca Pharmaceuticals LP $68.7405/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105579344 CMS
AstraZeneca Pharmaceuticals LP $46.9005/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105853194 CMS
AstraZeneca Pharmaceuticals LP $104.2605/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104354656 CMS
AstraZeneca Pharmaceuticals LP $124.6205/21/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105214773 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $258,698.30 345
PY2020 $99,705.09 125
PY2021 $103,212.10 159
PY2022 $152,591.83 249
PY2023 $188,895.63 309
PY2024 $162,930.63 262
PY2025 $185,626.39 286

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $2,623.76 22
PY2024 Principal investigator $16,936.77 223
PY2023 Principal investigator $54,931.21 36
PY2022 Recipient $750.00 2
PY2022 Principal investigator $43,411.35 36
PY2021 Recipient $1,500.00 4
PY2021 Principal investigator $107,322.54 28
PY2020 Principal investigator $108,154.12 10
PY2019 Principal investigator $116,672.54 23

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $61.13 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229177
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229179
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229181
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229215
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $68.41 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229217
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $70.50 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229219
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $113.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229233
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229235
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229237
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $68.41 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229239
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $68.41 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229249
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229251
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $70.50 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229253
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229255
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $113.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229257
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $61.13 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229259
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229261
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229263
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $65.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229265
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $70.50 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229267
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $113.81 08/20/2025 Non-covered Recipient Entity
ASTHMA NASAL DISEASE AND ALLERGY RESEARCH CENTER OF NEW ENGLAND
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184229269
Principal investigator 1 GlaxoSmithKline, LLC. $1,085.24 01/28/2025 Non-covered Recipient Entity
ALLERGY RESEARCH CENTER OF NEW ENGLAND
A RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP PHASE III STUDY TO ASSESS T No dispute reported 06/30/2026 1192108966